Quarterly report pursuant to Section 13 or 15(d)

Stock-based Compensation (Tables)

v3.24.1.u1
Stock-based Compensation (Tables)
3 Months Ended
Mar. 31, 2024
Share-Based Payment Arrangement [Abstract]  
Schedule of Equtiy Compensation Plan by Arrangements

The following table contains information about the Company’s stock plan at March 31, 2024:

 

    Awards
Reserved for
Issuance
    Awards
Issued &
Exercised
    Awards
Available
for Grant
 
2013 Equity Compensation Plan     62,984,400 *     50,712,275 **     12,272,125  

 

* Increased by 8,690,581 on January 1, 2024, representing 4% of the total number of shares of common stock outstanding on December 31, 2023.
** Includes both restricted stock grants and option grants
Schedule of Recognized Stock Based Compensation

The Company recognized stock-based compensation expense (options and restricted share grants) in its condensed consolidated statements of operations as follows:

 

    Three Months Ended March 31,  
    2024     2023  
Research and Development   $ 415     $ 553  
General and Administrative     580       719  
Total   $ 995     $ 1,272  
Schedule of Stock Option Activity

The following table summarizes the activity for Company’ stock options for the three months ended March 31, 2024:

 

    Stock Options  
Outstanding at December 31, 2023     46,707,934  
Granted      
Exercised      
Forfeited      
Expired     (676,374 )
Outstanding at March 31, 2024     46,031,560